Regent Peak Wealth Advisors LLC decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 12.7% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,947 shares of the healthcare conglomerate’s stock after selling 284 shares during the quarter. Regent Peak Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $920,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Axiom Financial Strategies LLC purchased a new stake in UnitedHealth Group in the 1st quarter worth about $210,000. McGowan Group Asset Management Inc. lifted its stake in UnitedHealth Group by 8.9% in the 1st quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after acquiring an additional 61 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in UnitedHealth Group by 31.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock worth $127,592,000 after acquiring an additional 60,300 shares in the last quarter. MAS Advisors LLC lifted its stake in UnitedHealth Group by 10.8% in the 1st quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock worth $241,000 after acquiring an additional 45 shares in the last quarter. Finally, First Western Trust Bank purchased a new stake in UnitedHealth Group in the 1st quarter worth about $875,000. Institutional investors and hedge funds own 92.61% of the company’s stock.
UnitedHealth Group Stock Performance
UNH opened at $461.58 on Friday. The firm has a market capitalization of $429.74 billion, a P/E ratio of 21.11, a price-to-earnings-growth ratio of 1.35 and a beta of 0.66. The stock’s 50 day moving average price is $481.95 and its two-hundred day moving average price is $488.15. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12-month low of $445.68 and a 12-month high of $558.10.
UnitedHealth Group Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 27th. Stockholders of record on Monday, June 19th were issued a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.63%. The ex-dividend date of this dividend was Thursday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.65. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.39%.
Insider Transactions at UnitedHealth Group
In related news, EVP Erin Mcsweeney sold 1,008 shares of the business’s stock in a transaction on Friday, April 21st. The stock was sold at an average price of $484.58, for a total value of $488,456.64. Following the sale, the executive vice president now owns 10,359 shares of the company’s stock, valued at approximately $5,019,764.22. The sale was disclosed in a legal filing with the SEC, which is available through this link. In related news, EVP Erin Mcsweeney sold 1,008 shares of the business’s stock in a transaction on Friday, April 21st. The stock was sold at an average price of $484.58, for a total value of $488,456.64. Following the sale, the executive vice president now owns 10,359 shares of the company’s stock, valued at approximately $5,019,764.22. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Andrew Witty sold 6,160 shares of the business’s stock in a transaction on Thursday, April 27th. The shares were sold at an average price of $487.49, for a total value of $3,002,938.40. Following the completion of the sale, the chief executive officer now directly owns 86,564 shares in the company, valued at approximately $42,199,084.36. The disclosure for this sale can be found here. In the last quarter, insiders have sold 8,852 shares of company stock valued at $4,313,962. 0.35% of the stock is owned by corporate insiders.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on UNH shares. Raymond James reaffirmed a “strong-buy” rating and set a $630.00 price target on shares of UnitedHealth Group in a research note on Friday, April 14th. Loop Capital raised their price target on UnitedHealth Group from $590.00 to $600.00 and gave the stock a “buy” rating in a research note on Monday, April 17th. Cantor Fitzgerald started coverage on UnitedHealth Group in a research note on Thursday, April 20th. They set an “overweight” rating and a $591.00 price target for the company. StockNews.com downgraded UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 14th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $592.00 price objective on shares of UnitedHealth Group in a research note on Monday, April 17th. One analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and a consensus price target of $590.84.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- MarketBeat Week in Review – 7/3 – 7/7
- Pfizer Just Invested $25 million In This Biotech
- Cracks In The Labor Market? Not Yet, But They’re Coming
- Levi’s: Buy On The Dip Or Downtrend In Play?
- Who Wins And Who Loses With China’s Metal Restrictions
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
